The Skin May Offer Clues About Parkinson’s Disease and Its Progression Over Time
CND Life Sciences is conducting a clinical research study to learn more about the progression…
DIAGNOSTIC INSIGHTS FOR LIFE™
CND’s Syn-One Test® offers physicians and patients an accurate, convenient, evidence-based tool to help diagnose a synucleinopathy. And our mission has just begun.
Introducing the Syn-One Test® from CND Life Sciences
The first commercially available skin-based test to help clinicians diagnose Parkinson’s disease and related disorders.
CLIA-Certified and CAP-Accredited Pathology Lab
Dedication to Science, Research, Quality, and Reliability
Patient-Focused Mission
High Accuracy: >95% Sensitivity and Specificity
Clarity and Confidence of Syn-One
Having objective, visual proof of a disease process can be invaluable for physicians and patients. That’s why CND Life Sciences developed the Syn-One Test as a way to actually see the presence of abnormal alpha-synuclein in the skin–an important marker for Parkinson’s disease and other disorders known as synucleinopathies.
Learn More
Our Commitment to Patients
We did not invent the saying “knowledge is power,” but we subscribe to this philosophy as part of our mission. Patients and caregivers rely on physicians to make vital clinical judgments every day, and we are committed to providing reliable diagnostic technologies and useful insights that help optimize care.
Learn more about what drives us.
Learn More
CND Insights
Read our perspectives on the industry, the field of neurodiagnostics, patient care, and other topics.
For Clinicians: Request a Skin Biopsy Test Kit
Our suite of neurodiagnostic tests provides clinicians with objective pathological insights on diseases that are often difficult to diagnose. Using our Skin Biopsy Test Kit, collect three small skin biopsies from your patient, send them to our CLIA-certified and CAP-accredited lab, and CND will provide important pathological insights to support a diagnosis.
Order a Kit
